News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,823 Results
Type
Article (40984)
Company Profile (275)
Press Release (664564)
Multimedia
Podcasts (55)
Webinars (12)
Section
Business (206358)
Career Advice (2011)
Deals (35737)
Drug Delivery (97)
Drug Development (82371)
Employer Resources (172)
FDA (16335)
Job Trends (15007)
News (349056)
Policy (32791)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2594)
Accelerated approval (5)
Adcomms (23)
Allergies (82)
Alliances (50224)
ALS (88)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (139)
Approvals (16334)
Artificial intelligence (257)
Autoimmune disease (22)
Automation (16)
Bankruptcy (361)
Best Places to Work (11773)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (199)
Bladder cancer (71)
Brain cancer (28)
Breast cancer (279)
Cancer (2254)
Cardiovascular disease (170)
Career advice (1679)
Career pathing (30)
CAR-T (153)
Cell therapy (421)
Cervical cancer (20)
Clinical research (66972)
Collaboration (835)
Compensation (525)
Complete response letters (20)
COVID-19 (2597)
CRISPR (38)
C-suite (239)
Cystic fibrosis (100)
Data (2109)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (263)
Diagnostics (6433)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (86995)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (113997)
Executive appointments (714)
FDA (17559)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (748)
Gene editing (102)
Generative AI (23)
Gene therapy (290)
GLP-1 (712)
Government (4440)
Grass and pollen (4)
Guidances (52)
Healthcare (19052)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (118)
Indications (28)
Infectious disease (2740)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (93)
Interviews (311)
IPO (16629)
IRA (41)
Job creations (3656)
Job search strategy (1426)
Kidney cancer (11)
Labor market (38)
Layoffs (480)
Leadership (16)
Legal (7939)
Liver cancer (76)
Lung cancer (327)
Lymphoma (148)
Machine learning (6)
Management (58)
Manufacturing (297)
MASH (65)
Medical device (13411)
Medtech (13416)
Mergers & acquisitions (19638)
Metabolic disorders (672)
Multiple sclerosis (78)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (27)
Neuroscience (1897)
NextGen: Class of 2025 (6578)
Non-profit (4512)
Northern California (2611)
Now hiring (39)
Obesity (361)
Opinion (210)
Ovarian cancer (75)
Pain (81)
Pancreatic cancer (82)
Parkinson's disease (147)
Partnered (21)
Patents (229)
Patient recruitment (107)
Peanut (46)
People (57953)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20921)
Phase II (29473)
Phase III (21991)
Pipeline (1149)
Policy (136)
Postmarket research (2594)
Preclinical (8826)
Press Release (64)
Prostate cancer (103)
Psychedelics (31)
Radiopharmaceuticals (257)
Rare diseases (375)
Real estate (5966)
Recruiting (65)
Regulatory (22458)
Reports (46)
Research institute (2369)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (68)
Series A (131)
Series B (84)
Service/supplier (11)
Sickle cell disease (53)
Southern California (2241)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3640)
State (2)
Stomach cancer (15)
Supply chain (67)
Tariffs (33)
The Weekly (35)
United States (22665)
Vaccines (686)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (15)
Date
Today (46)
Last 7 days (654)
Last 30 days (2407)
Last 365 days (33134)
2025 (9975)
2024 (35676)
2023 (40498)
2022 (51695)
2021 (56233)
2020 (54539)
2019 (47056)
2018 (35455)
2017 (32656)
2016 (32027)
2015 (38064)
2014 (31749)
2013 (26719)
2012 (28926)
2011 (29660)
2010 (27609)
Location
Africa (727)
Alabama (57)
Alaska (7)
Arizona (230)
Arkansas (13)
Asia (38558)
Australia (6307)
California (5969)
Canada (1973)
China (513)
Colorado (260)
Connecticut (266)
Delaware (139)
Europe (83773)
Florida (879)
Georgia (203)
Idaho (58)
Illinois (529)
India (25)
Indiana (306)
Iowa (11)
Japan (160)
Kansas (103)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (881)
Massachusetts (4514)
Michigan (216)
Minnesota (388)
Mississippi (2)
Missouri (81)
Montana (29)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1686)
New Mexico (28)
New York (1696)
North Carolina (959)
North Dakota (7)
Northern California (2611)
Ohio (200)
Oklahoma (14)
Oregon (34)
Pennsylvania (1344)
Puerto Rico (11)
Rhode Island (32)
South America (1108)
South Carolina (22)
South Dakota (1)
Southern California (2241)
Tennessee (102)
Texas (885)
Utah (177)
Virginia (140)
Washington D.C. (62)
Washington State (547)
West Virginia (3)
Wisconsin (53)
705,823 Results for "curelab oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
CureLab Oncology Files Patent Application for Groundbreaking Wound-Healing Therapy
CureLab Oncology, a clinical-stage biotech company, has filed a patent application with worldwide potential for a revolutionary wound-healing therapy based on its p62/SQSTM1 DNA plasmid.
June 27, 2024
·
2 min read
Press Releases
CureLab Oncology Appoints Dr. Aubrey C. Galloway as Chief Medical Officer
July 11, 2024
·
3 min read
Genetown
CureLab Receives $3M from Prominent Biotech Investor Dr. John Ballantyne
The co-founder of Aldevron, Dr. John Ballantyne, has invested $3M in CureLab Oncology and CureLab Veterinary.
March 2, 2023
·
3 min read
Press Releases
Jabez Biosciences, Inc. Announces First Patient Dosed in Phase 1 Oncology Clinical Study of JBZ-001
April 3, 2025
·
3 min read
Press Releases
Taiho Oncology to Share Data in Five Presentations, Including Two Oral Presentations, at the 2025 American Society of Clinical Oncology Annual Meeting
April 23, 2025
·
4 min read
Press Releases
Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2025
·
7 min read
Press Releases
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc.
February 26, 2025
·
4 min read
Press Releases
Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025
April 25, 2025
·
5 min read
Press Releases
Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)
April 3, 2025
·
2 min read
Collaboration
Incyte Backs Out of Immuno-Oncology Pact With Agenus
The partnership dates back to 2015, when Incyte paid $60 million upfront for access to four checkpoint programs, including TIM-3, LAG-3, OX40 and GITR.
February 12, 2025
·
2 min read
·
Tristan Manalac
1 of 70,583
Next
